A Model-Based Strategy to Control the Spread of Carbapenem-Resistant Enterobacteriaceae: Simulate and Implement

Carregando...
Imagem de Miniatura
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
CAMBRIDGE UNIV PRESS
Citação
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, v.37, n.11, p.1315-1322, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE. To reduce transmission of carbapenem-resistant Enterobacteriaceae (CRE) in an intensive care unit with interventions based on simulations by a developed mathematical model. DESIGN. Before-after trial with a 44-week baseline period and 24-week intervention period. SETTING. Medical intensive care unit of a tertiary care teaching hospital. PARTICIPANTS. All patients admitted to the unit. METHODS. We developed a model of transmission of CRE in an intensive care unit and measured all necessary parameters for the model input. Goals of compliance with hand hygiene and with isolation precautions were established on the basis of the simulations and an intervention was focused on reaching those metrics as goals. Weekly auditing and giving feedback were conducted. RESULTS. The goals for compliance with hand hygiene and contact precautions were reached on the third week of the intervention period. During the baseline period, the calculated R0 was 11; the median prevalence of patients colonized by CRE in the unit was 33%, and 3 times it exceeded 50%. In the intervention period, the median prevalence of colonized CRE patients went to 21%, with a median weekly Rn of 0.42 (range, 0-2.1). CONCLUSIONS. The simulations helped establish and achieve specific goals to control the high prevalence rates of CRE and reduce CRE transmission within the unit. The model was able to predict the observed outcomes. To our knowledge, this is the first study in infection control to measure most variables of a model in real life and to apply the model as a decision support tool for intervention.
Palavras-chave
Referências
  1. Bhargava A, 2014, INFECT CONT HOSP EP, V35, P398, DOI 10.1086/675614
  2. Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647
  3. D'Agata EMC, 2005, J INFECT DIS, V192, P2004, DOI 10.1086/498041
  4. Feldman N, 2013, CLIN MICROBIOL INFEC, V19, pE190, DOI 10.1111/1469-0691.12099
  5. GAYNES RP, 1992, INFECT CONT HOSP EP, V13, P10
  6. Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202
  7. Ivers N, 2012, COCHRANE DB SYST REV, V13
  8. LARSON EL, 1980, J CLIN MICROBIOL, V12, P355
  9. Lin MY, 2014, INFECT CONT HOSP EP, V35, P440, DOI 10.1086/675613
  10. MASSAD E, 1994, MATH BIOSCI, V123, P227, DOI 10.1016/0025-5564(94)90013-2
  11. Pereira GH, 2013, MEM I OSWALDO CRUZ, V108, P113, DOI 10.1590/S0074-02762013000100019
  12. Rossi F, 2011, CLIN INFECT DIS, V52, P1138, DOI 10.1093/cid/cir120
  13. Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770
  14. Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270
  15. Sypsa V, 2012, PLOS ONE
  16. van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294
  17. World Health Organization (WHO), 2009, WHO GUID HAND HYG HL
  18. Zimmerman FS, 2013, AM J INFECT CONTROL, V41, P190, DOI 10.1016/j.ajic.2012.09.020